Guideline concordance in triple‐negative breast cancer: What does it measure?

Key Points

• The aim is to assess the impact of guideline concordance on survival rates in triple-negative breast cancer, while considering external influences.
• Analysis of guideline concordance in treatment plans for triple-negative breast cancer
• Review of survival outcomes associated with guideline-concordant care
• Consideration of patient and health system factors in treatment adherence
• Guideline-concordant care is linked to better survival rates in triple-negative breast cancer.
• Improved survival includes reduction in deaths from non-breast cancer causes.
• Broader health system and patient factors influence guideline adherence and outcomes.